PlainRecalls
FDA Drug Moderate Class II Terminated

CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96

Reported: April 10, 2013 Initiated: February 7, 2013 #D-237-2013

Product Description

CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96

Reason for Recall

Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.

Details

Units Affected
3 boxes
Distribution
NC
Location
Sellersville, PA

Frequently Asked Questions

What product was recalled?
CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96. Recalled by Teva Pharmaceuticals USA, Inc.. Units affected: 3 boxes.
Why was this product recalled?
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 10, 2013. Severity: Moderate. Recall number: D-237-2013.